RAF kinase fusions, such as of BRAF or RAF1 (also known as CRAF), have been reported in various tumor types, including prostate cancer, GC, melanoma, and papillary thyroid cancer [1, 29]. This evidence concerns the gene BRAF and prostate cancer.